NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Wednesday that its fourth quarter revenues rose 6 percent, largely due to a 13 percent uptick in its clinical labs segment driven by increased sales of its molecular diagnostics tests.

For the three months ended July 31, the company reported total revenues of $28.2 million, up from $26.6 million a year earlier.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.